Login to Your Account

Marathon unloads Emflaza to PTC for $140M

By Marie Powers
News Editor

Thursday, March 16, 2017

One day after Sen. Bernie Sanders and Rep. Elijah Cummings penned a four-page letter to the FDA, about last month's approval of Emflaza, the drug's sponsor, Marathon Pharmaceuticals LLC, agreed to sell the drug to PTC Therapeutics Inc.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription